Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 9, Pages 2227
Publisher
MDPI AG
Online
2021-05-06
DOI
10.3390/cancers13092227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
- (2021) Orhan Aktas et al. ANNALS OF NEUROLOGY
- Current multidisciplinary management of brain metastases
- (2020) Michael J. Moravan et al. CANCER
- Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy
- (2020) Su-Hyun Kim et al. Scientific Reports
- Neurofilament Light Chain as A Biomarker for Brain Metastases
- (2020) Anne Winther-Larsen et al. Cancers
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
- (2019) Kristin N. Varhaug et al. Frontiers in Neurology
- Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis
- (2019) Yinan Zhao et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke
- (2019) Timo Uphaus et al. STROKE
- Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey
- (2018) Antonin Levy et al. EUROPEAN JOURNAL OF CANCER
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center
- (2018) L. M. Füreder et al. CLINICAL & EXPERIMENTAL METASTASIS
- Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value
- (2018) Lijuan Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- The expression of S100B protein in serum of patients with brain metastases from small-cell lung cancer and its clinical significance
- (2017) Shanling Mu et al. Oncology Letters
- Treatment of Brain Metastases
- (2015) Xuling Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Response assessment criteria for brain metastases: proposal from the RANO group
- (2015) Nancy U Lin et al. LANCET ONCOLOGY
- Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline
- (2013) M. J. Gil-Gil et al. Clinical & Translational Oncology
- Predicting brain metastases of breast cancer based on serum S100B and serum HER2
- (2013) TROELS BECHMANN et al. Oncology Letters
- S100B protein as a possible participant in the brain metastasis of NSCLC
- (2012) Xiaowen Pang et al. MEDICAL ONCOLOGY
- Epidemiology of Brain Metastases
- (2011) Lakshmi Nayak et al. Current Oncology Reports
- Astroglial Proteins as Diagnostic Markers of Acute Intracerebral Hemorrhage—Pathophysiological Background and Clinical Findings
- (2010) Robert Brunkhorst et al. Translational Stroke Research
- Molecular dissection of reactive astrogliosis and glial scar formation
- (2009) Michael V. Sofroniew TRENDS IN NEUROSCIENCES
- Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization
- (2008) Daniel P. Fitzgerald et al. CLINICAL & EXPERIMENTAL METASTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More